Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis. - Gross CC; Ahmetspahic D; Ruck T; Schulte-Mecklenbeck A; Schwarte K; Jörgens S; Scheu S; Windhagen S; Graefe B; Melzer N; Klotz L; Arolt V; et al. (Neurology(R) neuroimmunology & neuroinflammation, 2016)